Literature DB >> 18039132

The role of hypoxia in vascular injury and repair.

Tony E Walshe1, Patricia A D'Amore.   

Abstract

Although the terms ischemia and hypoxia are often used interchangeably, they represent distinct processes that result in different modulatory effects at the cellular level. Hypoxia is a reduction in oxygen delivery below tissue demand, whereas ischemia is a lack of perfusion, characterized not only by hypoxia but also by insufficient nutrient supply. Hypoxia can be either acute or chronic, and both are centrally regulated by hypoxia-inducible factor, a transcription factor that governs the expression of key response genes such as vascular endothelial growth factor and erythropoietin. Whereas severe chronic hypoxia can cause cell death, less-severe hypoxia can protect against subsequent damage, a phenomenon known as hypoxic conditioning. Several important processes are characterized by hypoxia, including ischemia-reperfusion, tumor growth and progression, inflammation, myocardial ischemia, and a number of ocular pathologies.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18039132     DOI: 10.1146/annurev.pathmechdis.3.121806.151501

Source DB:  PubMed          Journal:  Annu Rev Pathol        ISSN: 1553-4006            Impact factor:   23.472


  23 in total

1.  Alteration of developmental and pathological retinal angiogenesis in angptl4-deficient mice.

Authors:  Elisa Gomez Perdiguero; Ariane Galaup; Mélanie Durand; Jérémie Teillon; Josette Philippe; David M Valenzuela; Andrew J Murphy; George D Yancopoulos; Gavin Thurston; Stéphane Germain
Journal:  J Biol Chem       Date:  2011-08-05       Impact factor: 5.157

Review 2.  The Norrin/Frizzled4 signaling pathway in retinal vascular development and disease.

Authors:  Xin Ye; Yanshu Wang; Jeremy Nathans
Journal:  Trends Mol Med       Date:  2010-08-03       Impact factor: 11.951

3.  Oxygen tension and gradient measurements in the retinal microvasculature of rats.

Authors:  Pang-Yu Teng; Norman P Blair; Justin Wanek; Mahnaz Shahidi
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2011-11-19       Impact factor: 3.117

4.  Vascular risk and Aβ interact to reduce cortical thickness in AD vulnerable brain regions.

Authors:  Sylvia Villeneuve; Bruce R Reed; Cindee M Madison; Miranka Wirth; Natalie L Marchant; Stephen Kriger; Wendy J Mack; Nerses Sanossian; Charles DeCarli; Helena C Chui; Michael W Weiner; William J Jagust
Journal:  Neurology       Date:  2014-06-06       Impact factor: 9.910

5.  Aging influences cardiac mitochondrial gene expression and cardiovascular function following hemorrhage injury.

Authors:  Bixi Jian; Shaolong Yang; Dongquan Chen; Luyun Zou; John C Chatham; Irshad Chaudry; Raghavan Raju
Journal:  Mol Med       Date:  2010-12-22       Impact factor: 6.354

6.  CNS hypoxia is more pronounced in murine cerebral than noncerebral malaria and is reversed by erythropoietin.

Authors:  Casper Hempel; Valery Combes; Nicholas Henry Hunt; Jørgen Anders Lindholm Kurtzhals; Georges Emile Raymond Grau
Journal:  Am J Pathol       Date:  2011-08-18       Impact factor: 4.307

7.  Effects of creatine in a rat intestinal model of ischemia/reperfusion injury.

Authors:  M N Orsenigo; C Porta; C Sironi; U Laforenza; G Meyer; M Tosco
Journal:  Eur J Nutr       Date:  2011-06-23       Impact factor: 5.614

8.  HIF-1α Dependent Wound Healing Angiogenesis In Vivo Can Be Controlled by Site-Specific Lentiviral Magnetic Targeting of SHP-2.

Authors:  Yvonn Heun; Kristin Pogoda; Martina Anton; Joachim Pircher; Alexander Pfeifer; Markus Woernle; Andrea Ribeiro; Petra Kameritsch; Olga Mykhaylyk; Christian Plank; Florian Kroetz; Ulrich Pohl; Hanna Mannell
Journal:  Mol Ther       Date:  2017-04-20       Impact factor: 11.454

Review 9.  Erythropoietin and oxidative stress.

Authors:  Kenneth Maiese; Zhao Zhong Chong; Jinling Hou; Yan Chen Shang
Journal:  Curr Neurovasc Res       Date:  2008-05       Impact factor: 1.990

Review 10.  Stem cell therapies in the treatment of diabetic retinopathy and keratopathy.

Authors:  Andrei A Kramerov; Alexander V Ljubimov
Journal:  Exp Biol Med (Maywood)       Date:  2015-10-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.